Valery Fikkert

492 total citations
11 papers, 400 citations indexed

About

Valery Fikkert is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Valery Fikkert has authored 11 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 9 papers in Virology and 6 papers in Molecular Biology. Recurrent topics in Valery Fikkert's work include HIV/AIDS drug development and treatment (11 papers), HIV Research and Treatment (9 papers) and Biochemical and Molecular Research (5 papers). Valery Fikkert is often cited by papers focused on HIV/AIDS drug development and treatment (11 papers), HIV Research and Treatment (9 papers) and Biochemical and Molecular Research (5 papers). Valery Fikkert collaborates with scholars based in Belgium, United States and Italy. Valery Fikkert's co-authors include Myriam Witvrouw, Erik De Clercq, Christophe Pannecouque, Zeger Debyser, Barbara Van Remoortel, Terrence R. Burke, Nouri Neamati, Bénédicte Van Maele, Christoph H. Borchers and Raveendra Dayam and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Virology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Valery Fikkert

11 papers receiving 386 citations

Peers

Countries citing papers authored by Valery Fikkert

Since Specialization

Citations

This map shows the geographic impact of Valery Fikkert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Valery Fikkert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Valery Fikkert more than expected).

Fields of papers citing papers by Valery Fikkert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Valery Fikkert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Valery Fikkert. The network helps show where Valery Fikkert may publish in the future.

Co-authorship network of co-authors of Valery Fikkert

This figure shows the co-authorship network connecting the top 25 collaborators of Valery Fikkert. A scholar is included among the top collaborators of Valery Fikkert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Valery Fikkert. Valery Fikkert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Discovery of a small-molecule HIV-1 integrase inhibitor-binding site 2006 ·Proceedings of the National Academy of Sciences ·Laith Q. Al‐Mawsawi, Valery Fikkert, Raveendra Dayam, Myriam Witvrouw, Terrence R. Burke, Christoph H. Borchers, Nouri Neamati	77
2	Identification of Authentic Inhibitors of HIV-1 Integration 2005 ·Lirias (KU Leuven) ·Myriam Witvrouw, Valery Fikkert, Jo Vercammen, Bénédicte Van Maele, Yves Engelborghs, Zeger Debyser	9
3	Mutations in Bothenvandgaggenes are required for HIV-1 resistance to the polysulfonic dendrimer SPL2923, as corroborated by chimeric virus technology 2005 ·Antiviral chemistry & chemotherapy ·(unknown), Valery Fikkert, Barbara Van Remoortel, Christophe Pannecouque, Peter Cherepanov, Barry Matthews, George Holan, Erik De Clercq, Anne–Mieke Vandamme, Zeger Debyser, Myriam Witvrouw	5
4	Resistance of Human Immunodeficiency Virus Type 1 to the High-Mannose Binding Agents Cyanovirin N and Concanavalin A 2005 ·Journal of Virology ·Myriam Witvrouw, Valery Fikkert, (unknown), Christophe Pannecouque, Barry R. O’Keefe, James B. McMahon, Leonidas Stamatatos, Erik De Clercq, Anders Bolmstedt	79
5	Multiple mutations in human immunodeficiency virus-1 integrase confer resistance to the clinical trial drug S-1360 2004 ·AIDS ·Valery Fikkert, Anneleen Hombrouck, Barbara Van Remoortel, Marc De Maeyer, Christophe Pannecouque, Erik De Clercq, Zeger Debyser, Myriam Witvrouw	63
6	Potent and Selective Inhibition of HIV and SIV by Prostratin Interacting with Viral Entry 2003 ·Antiviral chemistry & chemotherapy ·Myriam Witvrouw, Christophe Pannecouque, Valery Fikkert, (unknown), Barbara Van Remoortel, Marjan Hezareh, Erik De Clercq, Stephen J. Brown	14
7	Development of Resistance against Diketo Derivatives of Human Immunodeficiency Virus Type 1 by Progressive Accumulation of Integrase Mutations 2003 ·Journal of Virology ·Valery Fikkert, Bénédicte Van Maele, Jo Vercammen, (unknown), Barbara Van Remoortel, Martine Michiels, (unknown), Christophe Pannecouque, Marc De Maeyer, Yves Engelborghs, Erik De Clercq, Zeger Debyser, Myriam Witvrouw	80
8	Antiviral resistance to diketo acids is associated with the mutations T66I, L74M and S230R in the HIV-1 integrase gene 2002 ·Antiviral Research ·Myriam Witvrouw, Valery Fikkert, Bénédicte Van Maele, Christophe Pannecouque, Nouri Neamati, Terrence R. Burke, Godwin C. G. Pais, Erik De Clercq, Zeger Debyser	1
9	env Chimeric Virus Technology for Evaluating Human Immunodeficiency Virus Susceptibility to Entry Inhibitors 2002 ·Antimicrobial Agents and Chemotherapy ·Valery Fikkert, Peter Cherepanov, Kristel Van Laethem, (unknown), Barbara Van Remoortel, Christophe Pannecouque, Erik De Clercq, Zeger Debyser, Anne–Mieke Vandamme, Myriam Witvrouw	33
10	Inhibition of Human Immunodeficiency Virus Type 1 Integration by Diketo Derivatives 2002 ·Antimicrobial Agents and Chemotherapy ·Wim Pluymers, Godwin C. G. Pais, Bénédicte Van Maele, Christophe Pannecouque, Valery Fikkert, Terrence R. Burke, Erik De Clercq, Myriam Witvrouw, Nouri Neamati, Zeger Debyser	36
11	4 Viral entry as the primary target of anti-HIV activity of chicoric acid and its tetra-acetyl esters 2000 ·Antiviral Research ·Christophe Pannecouque, Wim Pluymers, Valery Fikkert, Nouri Neamati, Christophe Marchand, Terrence R. Burke, Yves Pommier, Erik De Clercq, Zeger Debyser, Myriam Witvrouw	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact